Literature DB >> 34551108

Quantifying the Impact of COVID-19 Nonpharmaceutical Interventions on Influenza Transmission in the United States.

Yuchen Qi1, Jeffrey Shaman2, Sen Pei2.   

Abstract

BACKGROUND: Nonpharmaceutical interventions (NPIs) have been implemented to suppress transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Evidence indicates that NPIs against coronavirus disease 2019 (COVID-19) may also have effects on transmission of seasonal influenza.
METHODS: In this study, we use an absolute humidity-driven susceptible-infectious-recovered-susceptible (SIRS) model to quantify the reduction of influenza incidence and transmission in the United States and US Department of Health and Human Services regions after implementation of NPIs in 2020. We investigate long-term effect of NPIs on influenza incidence by projecting influenza transmission at the national scale over the next 5 years, using the SIRS model.
RESULTS: We estimate that incidence of influenza A/H1 and B, which circulated in early 2020, was reduced by more than 60% in the United States during the first 10 weeks following implementation of NPIs. The reduction of influenza transmission exhibits clear geographical variation. After the control measures are relaxed, potential accumulation of susceptibility to influenza infection may lead to a large outbreak, the scale of which may be affected by length of the intervention period and duration of immunity to influenza.
CONCLUSIONS: Healthcare systems need to prepare for potential influenza patient surges and advocate vaccination and continued precautions.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  19; 2; COVID; CoV; SARS; influenza; influenza forecasting; nonpharmaceutical interventions

Mesh:

Year:  2021        PMID: 34551108      PMCID: PMC8522386          DOI: 10.1093/infdis/jiab485

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

Review 1.  Collateral Impact of Public Health and Social Measures on Respiratory Virus Activity during the COVID-19 Pandemic 2020-2021.

Authors:  Chiara Achangwa; Huikyung Park; Sukhyun Ryu; Moo-Sik Lee
Journal:  Viruses       Date:  2022-05-17       Impact factor: 5.818

2.  Cost-effectiveness of interventions for the prevention and control of COVID-19: Systematic review of 85 modelling studies.

Authors:  Lihui Zhou; Wenxin Yan; Shu Li; Hongxi Yang; Xinyu Zhang; Wenli Lu; Jue Liu; Yaogang Wang
Journal:  J Glob Health       Date:  2022-06-15       Impact factor: 7.664

3.  Sharp decline in rates of community respiratory viral detection among NIH Clinical Center patients during the COVID-19 pandemic.

Authors:  Michele Woolbert; Christine Spalding; Ninet Sinaii; Brooke K Decker; Tara N Palmore; David K Henderson
Journal:  Infect Control Hosp Epidemiol       Date:  2022-02-18       Impact factor: 6.520

4.  From Outbreak to Near Disappearance: How Did Non-pharmaceutical Interventions Against COVID-19 Affect the Transmission of Influenza Virus?

Authors:  Shuxuan Song; Qian Li; Li Shen; Minghao Sun; Zurong Yang; Nuoya Wang; Jifeng Liu; Kun Liu; Zhongjun Shao
Journal:  Front Public Health       Date:  2022-03-29

Review 5.  Influenza.

Authors:  Timothy M Uyeki; David S Hui; Maria Zambon; David E Wentworth; Arnold S Monto
Journal:  Lancet       Date:  2022-08-27       Impact factor: 202.731

6.  Was the Reduction in Seasonal Influenza Transmission during 2020 Attributable to Non-Pharmaceutical Interventions to Contain Coronavirus Disease 2019 (COVID-19) in Japan?

Authors:  Keita Wagatsuma; Iain S Koolhof; Reiko Saito
Journal:  Viruses       Date:  2022-06-28       Impact factor: 5.818

7.  Prediction of upcoming global infection burden of influenza seasons after relaxation of public health and social measures during the COVID-19 pandemic: a modelling study.

Authors:  Sheikh Taslim Ali; Yiu Chung Lau; Songwei Shan; Sukhyun Ryu; Zhanwei Du; Lin Wang; Xiao-Ke Xu; Dongxuan Chen; Jiaming Xiong; Jungyeon Tae; Tim K Tsang; Peng Wu; Eric H Y Lau; Benjamin J Cowling
Journal:  Lancet Glob Health       Date:  2022-11       Impact factor: 38.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.